SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001662252-16-000267
Filing Date
2016-11-22
Accepted
2016-11-22 15:43:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D sch13dmaguire.htm SC 13D 58221
  Complete submission text file 0001662252-16-000267.txt   59655
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Subject) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89709 | Film No.: 162013155
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Maguire Michael Scott (Filed by) CIK: 0001690490 (see all company filings)

Type: SC 13D